Huang Lab

Publications

Publications

Browse recent publications with filters for title, author, journal, and year.

Last updated

July 20, 2026

Showing 76–100 of 143 publications · Page 4 of 6

2018

Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models

Wang J, Hayashi Y, Yokota A, Xu Z, Zhang Y, Huang R, Yan X, Liu H, Ma L, Azam M, Bridges JP, Cancelas JA, Kalfa TA, An X, Xiao Z, Huang G

Haematologica · 2018 Jan · PMID 29051279

View on PubMed DOI: 10.3324/haematol.2017.172775

2017

Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes

Tang YT, Wang D, Luo H, Xiao M, Zhou HS, Liu D, Ling SP, Wang N, Hu XL, Luo Y, Mao X, Ao QL, Huang J, Zhang W, Sheng LS, Zhu LJ, Shang Z, Gao LL, Zhang PL, Zhou M, Zhou KG, Qiu LG, Liu QF, Zhang HY, Li JY, Jin J, Fu L, Zhao WL, Chen JP, Du X, Huang G, Wang QF, Zhou JF, Huang L

Blood cancer journal · 2017 Dec 21 · PMID 29263371

View on PubMed DOI: 10.1038/s41408-017-0021-z

2017

HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis

Huang R, Hayashi Y, Yan X, Bu J, Wang J, Zhang Y, Zhou Y, Tang Y, Wu L, Xu Z, Liu X, Wang Q, Zhou J, Xiao Z, Bridges JP, Marsh RA, Zhang K, Jordan MB, Li Y, Huang G

Haematologica · 2017 Nov · PMID 28860338

View on PubMed DOI: 10.3324/haematol.2017.174979

2017

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis

Li B, Gale RP, Xu Z, Qin T, Song Z, Zhang P, Bai J, Zhang L, Zhang Y, Liu J, Huang G, Xiao Z

Journal of hematology & oncology · 2017 May 2 · PMID 28464892

View on PubMed DOI: 10.1186/s13045-017-0472-5

2017

MLF1IP promotes normal erythroid proliferation and is involved in the pathogenesis of polycythemia vera

Feng G, Zhang T, Liu J, Ma X, Li B, Yang L, Zhang Y, Xu Z, Qin T, Zhou J, Huang G, Shi L, Xiao Z

FEBS letters · 2017 Mar · PMID 28173615

View on PubMed DOI: 10.1002/1873-3468.12587

2017

Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes

Wang J, Ai X, Qin T, Xu Z, Zhang Y, Liu J, Li B, Fang L, Zhang H, Pan L, Hu N, Qu S, Cai W, Ru K, Jia Y, Huang G, Xiao Z

Oncotarget · 2017 Jan 3 · PMID 27906673

View on PubMed DOI: 10.18632/oncotarget.13688

2016

Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis

Li B, Zhang P, Feng G, Xu Z, Qin T, Zhang Y, Sha Z, Dong D, Zhang H, Fang L, Pan L, Hu N, Qu S, Cai W, Huang G, Xiao Z

Blood cancer journal · 2016 Dec 9 · PMID 27935577

View on PubMed DOI: 10.1038/bcj.2016.116

2016

Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment

Dong L, Yu WM, Zheng H, Loh ML, Bunting ST, Pauly M, Huang G, Zhou M, Broxmeyer HE, Scadden DT, Qu CK

Nature · 2016 Nov 10 · PMID 27783593

View on PubMed DOI: 10.1038/nature20131

2016

Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R

Li B, Liu J, Qu S, Gale RP, Song Z, Xing R, Liu J, Ren Y, Xu Z, Qin T, Zhang Y, Fang L, Zhang H, Pan L, Hu N, Cai W, Zhang P, Huang G, Xiao Z

Oncotarget · 2016 Oct 18 · PMID 27655727

View on PubMed DOI: 10.18632/oncotarget.12105

2016

Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation

Link KA, Lin S, Shrestha M, Bowman M, Wunderlich M, Bloomfield CD, Huang G, Mulloy JC

Proceedings of the National Academy of Sciences of the United States of America · 2016 Aug 9 · PMID 27457952

View on PubMed DOI: 10.1073/pnas.1524225113

2016

The different prognostic impact of type-1 or type-1 like and type-2 or type-2 like CALR mutations in patients with primary myelofibrosis

Li B, Xu Z, Li Y, Peter Gale R, Song Z, Ai X, Qin T, Zhang Y, Zhang P, Huang G, Xiao Z

American journal of hematology · 2016 Jul · PMID 27059877

View on PubMed DOI: 10.1002/ajh.24378

2016

Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin

Man N, Sun XJ, Tan Y, García-Cao M, Liu F, Cheng G, Hatlen M, Xu H, Shah R, Chastain N, Liu N, Huang G, Zhou Y, Sheng M, Song J, Yang FC, Benezra R, Nimer SD, Wang L

Blood · 2016 May 12 · PMID 26944543

View on PubMed DOI: 10.1182/blood-2015-11-677708

2016

SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes

Kim JH, Baddoo MC, Park EY, Stone JK, Park H, Butler TW, Huang G, Yan X, Pauli-Behn F, Myers RM, Tan M, Flemington EK, Lim ST, Ahn EY

Molecular cell · 2016 Mar 17 · PMID 26990989

View on PubMed DOI: 10.1016/j.molcel.2016.02.024

2016

Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation

Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-Rachamimov AO, Spinner RJ, Largaespada DA, Ratner N

Cell reports · 2016 Mar 1 · PMID 26904939

View on PubMed DOI: 10.1016/j.celrep.2016.01.074

2016

RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity

Chin DW, Sakurai M, Nah GS, Du L, Jacob B, Yokomizo T, Matsumura T, Suda T, Huang G, Fu XY, Ito Y, Nakajima H, Osato M

Blood cancer journal · 2016 Jan 8 · PMID 26745853

View on PubMed DOI: 10.1038/bcj.2015.105

2016

TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia

Cui Y, Tong H, Du X, Li B, Gale RP, Qin T, Liu J, Xu Z, Zhang Y, Huang G, Jin J, Fang L, Zhang H, Pan L, Hu N, Qu S, Xiao Z

Stem cell investigation · 2016 · PMID 27777939

View on PubMed DOI: 10.21037/sci.2016.09.04

2015

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis

Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick S, Ivanov A, Pugacheva E, Bunting KD, Moriggl R, Kenner L, Tse W

Oncotarget · 2015 Aug 21 · PMID 26079538

View on PubMed DOI: 10.18632/oncotarget.4136

2015

Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression

Wang L, Man N, Sun XJ, Tan Y, García-Cao M, Liu F, Hatlen M, Xu H, Huang G, Mattlin M, Mehta A, Rampersaud E, Benezra R, Nimer SD

Blood · 2015 Jul 30 · PMID 26084673

View on PubMed DOI: 10.1182/blood-2015-03-635532

2015

MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition

Kühn MW, Hadler MJ, Daigle SR, Koche RP, Krivtsov AV, Olhava EJ, Caligiuri MA, Huang G, Bradner JE, Pollock RM, Armstrong SA

Haematologica · 2015 May · PMID 25596271

View on PubMed DOI: 10.3324/haematol.2014.115337

2015

MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia

Roychoudhury J, Clark JP, Gracia-Maldonado G, Unnisa Z, Wunderlich M, Link KA, Dasgupta N, Aronow B, Huang G, Mulloy JC, Kumar AR

Blood · 2015 Apr 16 · PMID 25740828

View on PubMed DOI: 10.1182/blood-2014-09-599258